|
Gene: ATP5PO |
Gene summary for ATP5PO |
Gene summary. |
Gene information | Species | Human | Gene symbol | ATP5PO | Gene ID | 539 |
Gene name | ATP synthase peripheral stalk subunit OSCP | |
Gene Alias | ATP5O | |
Cytomap | 21q22.11 | |
Gene Type | protein-coding | GO ID | GO:0006091 | UniProtAcc | P48047 |
Top |
Malignant transformation analysis |
Identification of the aberrant gene expression in precancerous and cancerous lesions by comparing the gene expression of stem-like cells in diseased tissues with normal stem cells |
Malignant transformation involving gene list. |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
539 | ATP5PO | GSM4909281 | Human | Breast | IDC | 4.93e-10 | 5.12e-01 | 0.21 |
539 | ATP5PO | GSM4909282 | Human | Breast | IDC | 6.68e-11 | 5.52e-01 | -0.0288 |
539 | ATP5PO | GSM4909285 | Human | Breast | IDC | 3.60e-66 | 1.08e+00 | 0.21 |
539 | ATP5PO | GSM4909286 | Human | Breast | IDC | 3.38e-21 | 4.71e-01 | 0.1081 |
539 | ATP5PO | GSM4909293 | Human | Breast | IDC | 4.37e-09 | -1.26e-01 | 0.1581 |
539 | ATP5PO | GSM4909294 | Human | Breast | IDC | 3.00e-10 | 5.49e-01 | 0.2022 |
539 | ATP5PO | GSM4909296 | Human | Breast | IDC | 1.10e-05 | 3.67e-01 | 0.1524 |
539 | ATP5PO | GSM4909297 | Human | Breast | IDC | 8.68e-07 | 1.95e-01 | 0.1517 |
539 | ATP5PO | GSM4909298 | Human | Breast | IDC | 1.75e-19 | 5.55e-01 | 0.1551 |
539 | ATP5PO | GSM4909299 | Human | Breast | IDC | 5.66e-04 | 4.06e-01 | 0.035 |
539 | ATP5PO | GSM4909301 | Human | Breast | IDC | 1.04e-03 | 3.97e-01 | 0.1577 |
539 | ATP5PO | GSM4909304 | Human | Breast | IDC | 3.56e-05 | 2.28e-01 | 0.1636 |
539 | ATP5PO | GSM4909305 | Human | Breast | IDC | 2.53e-11 | 4.70e-01 | 0.0436 |
539 | ATP5PO | GSM4909306 | Human | Breast | IDC | 1.85e-11 | 4.44e-01 | 0.1564 |
539 | ATP5PO | GSM4909307 | Human | Breast | IDC | 1.38e-05 | 4.84e-01 | 0.1569 |
539 | ATP5PO | GSM4909308 | Human | Breast | IDC | 1.99e-33 | 7.07e-01 | 0.158 |
539 | ATP5PO | GSM4909311 | Human | Breast | IDC | 1.75e-24 | 7.24e-02 | 0.1534 |
539 | ATP5PO | GSM4909312 | Human | Breast | IDC | 3.21e-07 | 4.94e-01 | 0.1552 |
539 | ATP5PO | GSM4909315 | Human | Breast | IDC | 2.13e-03 | 4.14e-01 | 0.21 |
539 | ATP5PO | GSM4909316 | Human | Breast | IDC | 6.19e-06 | 5.56e-01 | 0.21 |
Page: 1 2 3 4 5 6 7 8 9 10 11 12 |
Transcriptomic changes along malignancy continuum. |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
Find out the enriched GO biological processes and KEGG pathways involved in transition from healthy to precancer to cancer |
Figure of enriched GO biological processes. |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | |
Colorectum | SER | |
Colorectum | MSS | |
Colorectum | MSI-H | |
Colorectum | FAP |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
Enriched GO biological processes. |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:000920623 | Breast | DCIS | purine ribonucleoside triphosphate biosynthetic process | 24/1390 | 68/18723 | 4.03e-11 | 5.74e-09 | 24 |
GO:000683923 | Breast | DCIS | mitochondrial transport | 51/1390 | 254/18723 | 5.04e-11 | 6.79e-09 | 51 |
GO:000914523 | Breast | DCIS | purine nucleoside triphosphate biosynthetic process | 24/1390 | 69/18723 | 5.75e-11 | 7.56e-09 | 24 |
GO:000675423 | Breast | DCIS | ATP biosynthetic process | 21/1390 | 57/18723 | 2.64e-10 | 3.11e-08 | 21 |
GO:000920123 | Breast | DCIS | ribonucleoside triphosphate biosynthetic process | 24/1390 | 74/18723 | 3.04e-10 | 3.44e-08 | 24 |
GO:000914423 | Breast | DCIS | purine nucleoside triphosphate metabolic process | 26/1390 | 88/18723 | 5.62e-10 | 5.89e-08 | 26 |
GO:000920523 | Breast | DCIS | purine ribonucleoside triphosphate metabolic process | 25/1390 | 82/18723 | 5.75e-10 | 5.91e-08 | 25 |
GO:000914223 | Breast | DCIS | nucleoside triphosphate biosynthetic process | 25/1390 | 85/18723 | 1.33e-09 | 1.33e-07 | 25 |
GO:000919923 | Breast | DCIS | ribonucleoside triphosphate metabolic process | 25/1390 | 89/18723 | 3.84e-09 | 3.24e-07 | 25 |
GO:000914123 | Breast | DCIS | nucleoside triphosphate metabolic process | 28/1390 | 112/18723 | 8.02e-09 | 6.30e-07 | 28 |
GO:199054222 | Breast | DCIS | mitochondrial transmembrane transport | 25/1390 | 102/18723 | 7.63e-08 | 4.45e-06 | 25 |
GO:000915223 | Breast | DCIS | purine ribonucleotide biosynthetic process | 34/1390 | 169/18723 | 7.77e-08 | 4.47e-06 | 34 |
GO:004639022 | Breast | DCIS | ribose phosphate biosynthetic process | 36/1390 | 190/18723 | 1.59e-07 | 8.19e-06 | 36 |
GO:000926022 | Breast | DCIS | ribonucleotide biosynthetic process | 35/1390 | 182/18723 | 1.62e-07 | 8.24e-06 | 35 |
GO:001969324 | Breast | DCIS | ribose phosphate metabolic process | 58/1390 | 396/18723 | 4.80e-07 | 2.11e-05 | 58 |
GO:000915024 | Breast | DCIS | purine ribonucleotide metabolic process | 55/1390 | 368/18723 | 4.92e-07 | 2.14e-05 | 55 |
GO:000925924 | Breast | DCIS | ribonucleotide metabolic process | 56/1390 | 385/18723 | 9.44e-07 | 3.79e-05 | 56 |
GO:000616422 | Breast | DCIS | purine nucleotide biosynthetic process | 34/1390 | 191/18723 | 1.56e-06 | 5.88e-05 | 34 |
GO:000616324 | Breast | DCIS | purine nucleotide metabolic process | 56/1390 | 396/18723 | 2.31e-06 | 8.29e-05 | 56 |
GO:000911723 | Breast | DCIS | nucleotide metabolic process | 65/1390 | 489/18723 | 3.19e-06 | 1.03e-04 | 65 |
Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 |
Enriched KEGG pathways. |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
hsa0501218 | Breast | Precancer | Parkinson disease | 99/684 | 266/8465 | 3.58e-42 | 5.65e-40 | 4.33e-40 | 99 |
hsa0502016 | Breast | Precancer | Prion disease | 95/684 | 273/8465 | 1.39e-37 | 1.46e-35 | 1.12e-35 | 95 |
hsa0501616 | Breast | Precancer | Huntington disease | 98/684 | 306/8465 | 2.85e-35 | 2.25e-33 | 1.72e-33 | 98 |
hsa0019016 | Breast | Precancer | Oxidative phosphorylation | 59/684 | 134/8465 | 6.15e-30 | 3.24e-28 | 2.48e-28 | 59 |
hsa0501016 | Breast | Precancer | Alzheimer disease | 103/684 | 384/8465 | 1.03e-29 | 4.66e-28 | 3.57e-28 | 103 |
hsa0501416 | Breast | Precancer | Amyotrophic lateral sclerosis | 98/684 | 364/8465 | 2.13e-28 | 8.41e-27 | 6.44e-27 | 98 |
hsa0502216 | Breast | Precancer | Pathways of neurodegeneration - multiple diseases | 112/684 | 476/8465 | 6.96e-27 | 2.44e-25 | 1.87e-25 | 112 |
hsa0520818 | Breast | Precancer | Chemical carcinogenesis - reactive oxygen species | 68/684 | 223/8465 | 3.61e-23 | 1.14e-21 | 8.73e-22 | 68 |
hsa0471418 | Breast | Precancer | Thermogenesis | 68/684 | 232/8465 | 4.40e-22 | 1.26e-20 | 9.69e-21 | 68 |
hsa0541518 | Breast | Precancer | Diabetic cardiomyopathy | 63/684 | 203/8465 | 5.63e-22 | 1.48e-20 | 1.14e-20 | 63 |
hsa0501219 | Breast | Precancer | Parkinson disease | 99/684 | 266/8465 | 3.58e-42 | 5.65e-40 | 4.33e-40 | 99 |
hsa0502017 | Breast | Precancer | Prion disease | 95/684 | 273/8465 | 1.39e-37 | 1.46e-35 | 1.12e-35 | 95 |
hsa0501617 | Breast | Precancer | Huntington disease | 98/684 | 306/8465 | 2.85e-35 | 2.25e-33 | 1.72e-33 | 98 |
hsa0019017 | Breast | Precancer | Oxidative phosphorylation | 59/684 | 134/8465 | 6.15e-30 | 3.24e-28 | 2.48e-28 | 59 |
hsa0501017 | Breast | Precancer | Alzheimer disease | 103/684 | 384/8465 | 1.03e-29 | 4.66e-28 | 3.57e-28 | 103 |
hsa0501417 | Breast | Precancer | Amyotrophic lateral sclerosis | 98/684 | 364/8465 | 2.13e-28 | 8.41e-27 | 6.44e-27 | 98 |
hsa0502217 | Breast | Precancer | Pathways of neurodegeneration - multiple diseases | 112/684 | 476/8465 | 6.96e-27 | 2.44e-25 | 1.87e-25 | 112 |
hsa0520819 | Breast | Precancer | Chemical carcinogenesis - reactive oxygen species | 68/684 | 223/8465 | 3.61e-23 | 1.14e-21 | 8.73e-22 | 68 |
hsa0471419 | Breast | Precancer | Thermogenesis | 68/684 | 232/8465 | 4.40e-22 | 1.26e-20 | 9.69e-21 | 68 |
hsa0541519 | Breast | Precancer | Diabetic cardiomyopathy | 63/684 | 203/8465 | 5.63e-22 | 1.48e-20 | 1.14e-20 | 63 |
Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 |
Top |
Cell-cell communication analysis |
Identification of potential cell-cell interactions between two cell types and their ligand-receptor pairs for different disease states |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
Find out the significant the regulons (TFs) and the target genes of each regulon across cell types for different disease states |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
Annotation of somatic variants for genes involved in malignant transformation |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
Page: 1 |
Top |
Related drugs of malignant transformation related genes |
Identification of chemicals and drugs interact with genes involved in malignant transfromation |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |